Skip to main content

ADVERTISEMENT

Onychomycosis

Blog
07/23/2020
Tracey Vlahovic DPM
Onychomycosis is a chronic fungal infection of the toenails and/or fingernails that has a global prevalence in children of 0.35 to 5.5 percent.1 Approximately 15 percent of all nail dystrophies in children are due to onychomycosis.2 Though...
Onychomycosis is a chronic fungal infection of the toenails and/or fingernails that has a global prevalence in children of 0.35 to 5.5 percent.1 Approximately 15 percent of all nail dystrophies in children are due to onychomycosis.2 Though...
Onychomycosis is a chronic...
07/23/2020
Podiatry Today
Reassessing Laser Treatment As An Alternative Option For Onychomycosis
Clinical Solutions in Practice
03/16/2020

By Jennifer Spector, DPM, FACFAS, Associate Editor

By Jennifer Spector, DPM, FACFAS, Ass...
Could an innovative technology help improve patient outcomes for onychomycosis and increase practice revenue? The PinPointe™ FootLaser® is a Food and Drug Administration (FDA)-cleared system for temporary increase of clear nail in patients...
Could an innovative technology help improve patient outcomes for onychomycosis and increase practice revenue? The PinPointe™ FootLaser® is a Food and Drug Administration (FDA)-cleared system for temporary increase of clear nail in patients...
Could an innovative technology...
03/16/2020
Podiatry Today
Online Exclusive
08/15/2019
Podiatry Today
Feature
09/24/2015

Keith Sklar, DPM, FACFAS

Keith Sklar, DPM, FACFAS
Emphasizing the treatment of onychomycosis as an infection and a cosmetic problem, this author offers insights from his experience with a synergistic management protocol and provides several case studies.
Emphasizing the treatment of onychomycosis as an infection and a cosmetic problem, this author offers insights from his experience with a synergistic management protocol and provides several case studies.
Emphasizing the treatment of...
09/24/2015
Podiatry Today
News and Trends
06/22/2015
Brian McCurdy, Managing Editor
Brian McCurdy, Managing Editor
Two recent phase III studies point to a new topical agent as an effective treatment option for onychomycosis.
Two recent phase III studies point to a new topical agent as an effective treatment option for onychomycosis.
Two recent phase III studies...
06/22/2015
Podiatry Today
08/20/2014
Dr. Vlahovic, I read with interest your feature article, “Current and Emerging Agents for Tinea Pedis,” in the April 2014 issue of Podiatry Today.
Dr. Vlahovic, I read with interest your feature article, “Current and Emerging Agents for Tinea Pedis,” in the April 2014 issue of Podiatry Today.
Dr. Vlahovic, I read with...
08/20/2014
Podiatry Today